← Leaderboards
Andrew Levin
Kephera Diagnostics, Llc
$2,899,958
Attributed
$2,899,958
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2019–24$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,899,958 · 4
By mechanism
N44$1,999,961 · 1
N43$600,000 · 2
N01$299,997 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionFasciola HepaticaBile Duct CarcinomaPublic HealthSmall Business Innovation Research GrantSoutheastern AsiaHuman ResourcesAffectOpisthorchis ViverriniPoint Of CareAreaServicesClonorchiasisClonorchis SinensisMilitary PersonnelGovernmentScreeningImmigrantOpisthorchiasisEnzyme-Linked Immunosorbent AssayCholangiocarcinomaFar EastBedside TestingsClinical Research
Grant awards (4)
SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections$300,000
N43 · FY2024 · AI · contact PI
TOPIC 388: IN VITRO DIAGNOSTIC FOR THE LIVER FLUKES OPISTHORCHIS VIVERRINI AND CLONORCHIS SINENSI$1,999,961
N44 · FY2021 · CA · contact PI
DIAGNOSTICS FOR CHAGAS DISEASE$300,000
N43 · FY2021 · AI · contact PI
SBIR Phase I Award Topic 388: Screening and Point of Care Diagnostic Assays for Opisthorchis Viverrini and Clonorchis Sinensis$299,997
N01 · FY2019 · CA · contact PI